SCHEMBL20231

SCHEMBL20231

Cc1c[nH]c(CO)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4455138 0.98
Hydrogen Peroxide SCHEMBL28136903 0.79 ADORA1 (0.36)
SCHEMBL17688 0.78
SCHEMBL28138740 0.78 ADORA1 (0.38)
Bromide SCHEMBL8534627 0.76
SCHEMBL1219898 0.76
SCHEMBL5439300 0.76
SCHEMBL542826 0.76
SCHEMBL9143102 0.76
SCHEMBL11854680 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119976829-A High-performance graphite-based carbon composite material and preparation method thereof 江苏中迪新材料技术有限公司 2025-05-13 CN claimed
CN-119607129-A Medicine for removing fetal marks 青岛痣和堂中医医疗管理有限公司 2025-03-14 CN claimed
EP-0006102-A1 1-Hydroxymethylimidazoles, their preparation and use as chemical intermediates BASF Aktiengesellschaft (DE) 1980-01-09 EP claimed
EP-4632004-A1 COMPOSITION, CURABLE COMPOSITION, CURED BODY, OPTICAL PRODUCT, LENS, EYEGLASSES, ANTIMICROBIAL/ANTIVIRAL AGENT, AND RESIN COMPOSITION TOKUYAMA CORPORATION (JP) 2025-10-15 EP disclosed
EP-4631981-A1 COMPOSITION, CURABLE COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, GLASSES, AND ANTIBACTERIAL/ANTIVIRAL AGENT TOKUYAMA CORPORATION (JP) 2025-10-15 EP disclosed
CN-119976829-A High-performance graphite-based carbon composite material and preparation method thereof 江苏中迪新材料技术有限公司 2025-05-13 CN disclosed
CN-119607129-A Medicine for removing fetal marks 青岛痣和堂中医医疗管理有限公司 2025-03-14 CN disclosed
CN-118436808-A Modified metal organic framework nanoparticle and preparation method and application thereof 上海交通大学 2024-08-06 CN disclosed
EP-4381120-A1 COMPOSITIONS AND METHODS FOR THE ELECTRODEPOSITION OF NANOTWINNED COPPER MacDermid Enthone Inc. (US) 2024-06-12 EP disclosed
US-11897764-B2 Porphyrazines as efficient, catalytic and scalable method to produce chlorine dioxide THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2024-02-13 US disclosed
WO-2023014524-A1 COMPOSITIONS AND METHODS FOR THE ELECTRODEPOSITION OF NANOTWINNED COPPER MACDERMID ENTHONE INC. (US) 2023-02-09 WO disclosed
WO-1998013350-A1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ZENECA LIMITED (GB) 1998-04-02 WO disclosed
WO-1998004560-A1 SUBSTITUTED TRIAZOLO PYRIDAZINE DERIVATIVES AS INVERSE AGONISTS OF THE GABAAα5 RECEPTOR SUBTYPE MERCK SHARP & DOHME LIMITED (GB) 1998-02-05 WO disclosed
US-5270322-A Imidazo[1,2-a]pyridines, pharmaceutical compositions containing these compounds and processes for preparing them DR. KARL THOMAE GMBH (DE) 1993-12-14 US disclosed
EP-0473626-A1 NEW DIPHOSPHONIC ACID DERIVATIVES, PROCESS FOR PRODUCING THEM AND DRUGS CONTAINING THEM. BOEHRINGER MANNHEIM GMBH (DE) 1992-03-11 EP disclosed
EP-0034725-B1 DYESTUFFS CONTAINING IMIDAZOLYLETHYLENE GROUPS AND THEIR USE BASF Aktiengesellschaft (DE) 1984-07-25 EP disclosed
US-4451398-A Dyes containing imidazolymethylene groups BASF AKTIENGESELLSCHAFT (DE) 1984-05-29 US disclosed
EP-0034725-A2 Dyestuffs containing imidazolylethylene groups and their use BASF Aktiengesellschaft (DE) 1981-09-02 EP disclosed
EP-0004534-B1 PREPARATION OF 4-METHYL-5-HYDROXYMETHYL-IMIDAZOLE EPROVA Aktiengesellschaft (CH) 1981-07-29 EP disclosed
EP-0006102-A1 1-Hydroxymethylimidazoles, their preparation and use as chemical intermediates BASF Aktiengesellschaft (DE) 1980-01-09 EP disclosed